CATEGORIES
CATEGORIES

19. January 2026
ARQIS advises GBS Electronic Solutions GmbH on the acquisition of productware

ARQIS advised GBS Electronic Solutions GmbH, a portfolio company of the mid-sized equity financier VR Equitypartner, on the acquisition of all shares in productware Gesellschaft zur Produktion von elektronischen Geräten mbH. The seller is Controlware Holding GmbH. The acquisition is carried out as part of the GBS EMS Group's buy-and-build strategy in the field of electronic manufacturing services (EMS). With this acquisition, the group is strengthening its position as a full-service partner for industrial customers while expanding its technological expertise and regional presence. At the same time, the GBS EMS Group is opening up new industrial end markets, including in the areas of railway technology, defense and IoT.

Productware Gesellschaft zur Produktion von elektronischen Geräten mbH, based in Dietzenbach, is a regionally established EMS specialist. The company manufactures high-quality electronic assemblies and complete devices (box builds) on high-end assembly lines and covers the entire range of services from development and series production to testing and logistics. Productware employs around 65 people and has more than 30 years of market experience.

GBS Electronic Solutions GmbH, based in Bayreuth, is a mid-sized technology company and positions itself as a full-service EMS provider along the entire value chain. VR Equitypartner has held a stake in the company since 2016 and supports it together with INDUC as a long-term growth partner. The aim is to develop the GBS EMS Group into one of the leading EMS providers in Germany.

An ARQIS team headed by Dr. Lars Laeger regularly advises VR Equitypartner and its portfolio companies and has already advised GBS on the acquisition of Elektron Systeme in 2022.

 

ARQIS (Dusseldorf): Dr. Lars Laeger (Partner, Transactions, Lead), Partner: Johannes Landry (Transactions), Dr. Ulrich Lienhard (Real Estate), Marcus Nothhelfer (IP, Munich), Counsel: Christian Judis (Compliance, Munich), Jens Knipping (Tax), Nora Stratmann (Commercial, Munich), Martin Weingärtner (HR Law), Managing Associates: Christina Huckschlag (Transactions), Tim Bresemann (Real Estate), Johanna Klingen (Data Law), Rolf Tichy (IP, Munich), Associate: Dr. Tim Weill (HR Law)


15. January 2026
ARQIS advises Karo Healthcare on the sale of Alpha Foods to Vision Healthcare

ARQIS has provided comprehensive legal advice to Karo Healthcare, a portfolio company of leading private equity firm KKR, on the sale of Alpha Foods to Vision Healthcare. The transaction strengthens Alpha Foods and enables the company's long-term growth. The parties have agreed not to disclose details of the transaction, such as the purchase price.

Karo Healthcare, headquartered in Stockholm, is a consumer healthcare company offering a broad product portfolio in the field of health and nutritional supplements. The company distributes products in over 90 countries and employs more than 470 people at 13 international locations.

Alpha Foods B.V., headquartered in Deurle, Belgium, offers natural, plant-based nutritional supplements. Its product range includes plant proteins, nutritional elixirs and supplements.

The Dutch company Vision Healthcare N.V. is a fast-growing omni-channel platform specializing in direct sales brands with a diverse portfolio of health and wellness brands. The company offers among other products cosmetics, dietary supplements, vitamins and non-prescription medications.

ARQIS, with a team headed by partner Dr. Jörn-Christian Schulze, advised Karo Healthcare on all legal aspects of the sale of Alpha Foods to Vision Healthcare. The team has provided legal advice to Karo Healthcare already on previous occasions. In spring 2024, ARQIS advised Karo Healthcare on the acquisition of Proctosedyl from Bayer.

 

Advisors to Karo Healthcare
ARQIS (Dusseldorf): Core Deal Team: Dr. Jörn-Christian Schulze (Partner, Lead), Dr. Maximilian Backhaus (Counsel, both Transactions), Counsel: Jens Knipping (Tax), Associate: Ivo Ertekin (Transactions)


9. January 2026
ARQIS advises CONSTELLATION CAPITAL on the acquisition of Abresch Industrieverpackung GmbH

ARQIS advised the Swiss investor group CONSTELLATION CAPITAL on all legal aspects of the acquisition of Abresch Industrieverpackung GmbH. Abresch Industrieverpackung GmbH will become part of the ARCA Group, which belongs to CONSTELLATION CAPITAL. With this step, ARCA Holding GmbH is systematically expanding the ARCA network for industrial packaging solutions and strengthening its own presence in southwestern Germany. Through the merger, Abresch Verpackung will benefit from expanded development potential, the ARCA Group's supraregional network and the associated diversified customer portfolio.

Abresch Industrieverpackung GmbH, based in Viernheim, employs over 50 people and is one of the established providers of industrial packaging solutions in southwestern Germany. The company has strengths in process-oriented cooperation with industrial customers. The focus is on factory packaging, intralogistics, series packaging and spare parts management for demanding industrial applications.

ARCA Holding GmbH, a group of CONSTELLATION CAPITAL, is to be expanded into the market leader in the field of wooden packaging and packaging services in German-speaking countries. ARCA's focus is on implementing a consolidation strategy to create a coherent network of mutually beneficial companies offering tailor-made packaging solutions and services.

CONSTELLATION CAPITAL AG is a Swiss investor group formed in 1992 and based in Freienbach on Lake Zurich. CONSTELLATION pursues a buy & build strategy that focuses on majority investments in medium-sized companies in the business services, education & lifestyle and healthcare sectors in the DACH region.

An ARQIS team headed by Dr. Lars Laeger provided comprehensive legal advice to CONSTELLATION CAPITAL on this transaction. The team advises CONSTELLATION CAPITAL on all platform acquisitions for the ARCA Group in legal and tax matters as well as on acquisition financing. ARQIS also provided legal advice on the acquisition of the platform.

ARQIS (Dusseldorf): Dr. Lars Laeger ARQIS (Düsseldorf): Dr. Lars Laeger (Partner, Transactions, Lead), Partner: Johannes Landry (Financing), Dr. Ulrich Lienhard (Real Estate), Counsel: Christian Judis (Compliance, Munich), Jens Knipping (Tax), Franziska Leubner (Munich), Martin Weingärtner (both HR Law), Nora Stratmann (Commercial, Munich), Managing Associates: David Hudde (Transactions), Tim Bresemann (Real Estate), Johanna Klingen (Data Law), Rolf Tichy (IP, Munich), Associates: Dr. Lina Alami (Munich), Dr. Tim Weill (both HR Law), Rebecca Gester (Commercial, Munich), Paulina Hüttner, Dr. Julia Wildgans (both IP, Munich), Lia Papismedova (Real Estate)


22. December 2025
ARQIS advises Kapital 1852 on the exit of the Physio CKI Group to Gilde Healthcare

ARQIS provided legal advice to Kapital 1852 and the founder and managing director of Physio CKI on the successful exit to Gilde Healthcare.

Chaled Qarizada, founder and managing director of Physio CKI, remains a significant shareholder in the group and will continue to lead the business. Kapital 1852 has successfully supported Physio CKI in recent years during its start-up and growth phase. The partnership with Gilde Healthcare now represents the next step in the company's development and is intended to be further accelerated through a successful greenfield approach.

Kapital 1852 is a fund platform initiated and advised by Hauck Aufhäuser Lampe Privatbank AG and comprises a direct investment fund focused on private equity, as well as funds of funds in the areas of venture capital, private debt, and infrastructure. The focus of the direct investment strategy within private equity is on structuring and financing company successions, the acquisition of corporate carve-outs, and expansion financing for small and medium-sized enterprises.

Physio CKI, headquartered in Cologne, provides physiotherapy services of the highest standard across 13 practices in the Rhein-Sieg, Cologne-Bonn, and Düsseldorf regions. The group employs over 200 people, making it one of the most successful physiotherapy chains in Germany.

ARQIS previously advised Chaled Qarizada on the entry of Kapital 1852. As part of the exit, the sponsor has once again chosen the team led by Dr. Jörn-Christian Schulze, which impressed with its healthcare expertise and interdisciplinary approach. A Livingstone team led by Christian Grandin acted as M&A advisor, as it had done for the entry.

ARQIS (Düsseldorf): Core Deal Team Dr. Jörn-Christian Schulze (Lead), Christos Choudeloudis (Managing Associate), Tim Meyer-Meisel (Associate, all Transactions), Partner: Dr. Mirjam Boche (Risk), Thomas Chwalek (Transactions), Johannes Landry (Restructuring & Insolvency), Dr. Ulrich Lienhard (Real Estate), Counsel: Jens Knipping (Tax), Martin Weingärtner (HR Law), Managing Associates: Tim Bresemann, Diana Puchowezki (both Real Estate), Dr. Bernhard Gröhe (Regulatory), Katrin Ludwig, Severin Steffens (both Transactions), Rolf Tichy (IP, Munich), Associates: Ivo Ertekin, Stella Tönnessen (both Transactions), Paulina Hüttner (IP, Munich), Lia Papismedova (Real Estate), Dr. Tim Weill (HR Law), Foreign Lawyer: Qing Xia


19. December 2025
ARQIS advises Lafayette Mittelstand Capital, shareholder of Argentum Gruppe, on the acquisition of Zerbst Pflege Gruppe

ARQIS provided comprehensive legal advice to the shareholder of Argentum Gruppe, the leading private equity firm Lafayette Mittelstand Capital, on the acquisition and successful restructuring of Alten- und Pflegeheim in Zerbst GmbH (Zerbst Pflege Gruppe). This ensured the continuity of operations for the Zerbst Pflege Gruppe, with all facilities at a total of eight locations being secured. At the same time, the acquisition enables further growth for the Argentum Gruppe. The parties involved have agreed not to disclose further details of the transaction. The acquisition remains subject to the usual regulatory approvals.

Alten- und Pflegeheim in Zerbst GmbH employs around 750 people and operates inpatient and outpatient care facilities as well as senior care facilities in Saxony-Anhalt, Lower Saxony, Berlin and Saxony.

Argentum Gruppe operates nursing and senior care facilities throughout Germany. Headquartered in Bad Homburg, the company currently operates 22 facilities with around 1,600 employees. It offers a wide range of services to over 2,000 residents, including full inpatient care, assisted living, short-term care and home care.

An ARQIS team headed by partners Johannes Landry and Dr. Ulrich Lienhard, as well as counsel Benjamin Bandur, advised the shareholder of Argentum Gruppe, Lafayette Mittelstand Capital, on all legal aspects of this transaction. ARQIS was recommended for the mandate by other market participants.

ARQIS (Dusseldorf): Johannes Landry (Partner, Restructuring and Insolvency), Dr. Ulrich Lienhard (Partner, Real Estate), Benjamin Bandur (Counsel, Transactions, Munich, all Core Deal Team), Partner: Dr. Mauritz von Einem (Transactions, Munich), Tobias Neufeld (Data Law), Counsel: Jens Knipping, Dennis Reisich (both Tax, Munich), Martin Weingärtner (HR Law), Managing Associate: Johanna Klingen (Data Law), Associates: Sabine Müller (HR Law, Munich), Lia Papismedova (Real Estate), Foreign Lawyer: Konstantinos Strempas (Transactions, Munich)

MARCK (Dusseldorf): Dr. Georg Schmittmann, Dr. Reto Batzel (both Partner, both Antitrust)


27. November 2025
ARQIS advises Agile Robots SE on the acquisition of thyssenkrupp Automation Engineering

ARQIS advised Agile Robots SE on all legal aspects of the acquisition of assets from systems manufacturer thyssenkrupp Automation Engineering in Europe and North America. Through this acquisition, Agile Robots plans to further strengthen its market position in next-generation smart automation solutions and is tapping into new growth markets. With the technological expertise, long-standing customer relationships and experience of thyssenkrupp Automation Engineering, Agile Robots intends to tap into new market segments and expand its presence in the US. Following the acquisition, the company will operate as Krause Automation within the Agile Robots Group.

The transaction is still subject to customary regulatory approvals and is expected to be completed in the coming months. The parties involved have agreed not to disclose the commercial details.

Agile Robots, headquartered in Munich, is a leading global provider of AI-powered robotic solutions. By combining artificial intelligence and robotics, the company makes industrial processes smarter, more flexible and more efficient. Since its founding in 2018, the company has grown into a global innovation leader and employs around 2,500 people in Germany, China and India.

thyssenkrupp Automation Engineering is an operating unit within the Automotive Technology segment of thyssenkrupp AG. Around 1,100 employees work across ten countries on three continents.

An ARQIS team headed by partner Dr. Mauritz von Einem provided comprehensive legal advice to Agile Robots SE on this transaction, which also included the global coordination of local counsel teams. Dr. Andrea Panzer-Heemeier and the ARQIS HR.Law team negotiated a best-and-fair owner agreement ahead of the transaction. As part of this agreement, Agile Robots, thyssenkrupp, employee representatives and IG Metall agreed on framework conditions for the further development of the German locations and their involvement into the ongoing integration process. Agile Robots, founded in 2018 by robotics researchers from the German Aerospace Center (DLR), has relied on ARQIS' expertise for many years, most recently in the acquisition of Idealworks from the BMW Group.

 

Advisors to Agile Robots SE
ARQIS (Munich): Core deal team: Dr. Mauritz von Einem (Global Lead, Partner, Transactions), Dennis Reisich (Counsel, Transactions/Tax), Giulia Kögel (Associate, Transactions), Konstantinos Strempas (Foreign Lawyer, Transactions), Dr. Andrea Panzer-Heemeier (Co-Lead, Partner, Labour, Düsseldorf), Dr. Roua Schmitz (Labour), Partner: Dr. Friedrich Gebert (Regulatory, Düsseldorf), Dr. Ulrich Lienhard (Real Estate, Düsseldorf), Tobias Neufeld (Pensions, Düsseldorf), Marcus Nothhelfer (IP/IT), Counsel: Benjamin Bandur (Transactions), Christian Judis (Compliance), Jens Knipping (Tax, Düsseldorf), Franziska Leubner, Martin Weingärtner (Düsseldorf, both Labour), Nora Stratmann (Commercial), Managing Associates: Tim Bresemann, Diana Puchowezki (both Real Estate, Düsseldorf), Anselm Graf (Transactions), Dr. Bernhard Gröhe (Regulatory), Rolf Tichy (IP/IT), Associates: Rebecca Gester (Commercial), Paulina Hüttner, Julia Wildgans (both IP/IT), Lia Papismedova (Real Estate, Düsseldorf), Dr. Tim Weill (Pensions, Düsseldorf)

MARCK (Düsseldorf): Dr. Georg Schmittmann, Dr. Reto Batzel (both Partner), Simon Philipp (Associate, all Antitrust)


11. November 2025
ARQIS advises on the sale of a majority stake in Herbrig & Co. GmbH to Borromin Capital Fund V SCSp

ARQIS has provided comprehensive legal advice to Christoph Herbrig, CEO and sole shareholder of Herbrig & Co. GmbH, on the sale of a majority stake to Borromin Capital Management GmbH. In particular, the Borromin Capital Fund V SCSp, advised by Borromin Capital Management, is acquiring the stake in the company. Christoph Herbrig and the existing management team will remain at the head of the company.

Herbrig & Co. GmbH is one of the leading manufacturers of high-quality precision turned parts and has been a reliable system partner for numerous international technology companies for many years, including the sensor technology, electrical engineering and e-mobility sectors. The company, headquartered in Altenberg, Saxony, employs around 200 people at three locations.

Borromin Capital Management GmbH, based in Frankfurt am Main, is a private equity company that invests primarily in medium-sized companies in German-speaking Europe and the Benelux countries. Since 2001, Borromin has been investing in profitable companies from a wide range of industries.

An ARQIS team headed by Dr. Jörn-Christian Schulze provided comprehensive legal advice to the CEO and sole shareholder of Herbrig & Co. GmbH on this transaction. MAYLAND AG acted as M&A advisor and process manager, on whose recommendation ARQIS was mandated as legal advisor.

 

Advisor to Herbrig & Co. GmbH
ARQIS (Dusseldorf): Dr. Jörn-Christian Schulze (Partner, Lead), Thomas Chwalek (Partner), Ivo Ertekin (Associate, all Transactions, Core-Dealteam), Partner: Johannes Landry (Financing), Dr. Ulrich Lienhard (Real Estate), Marcus Nothhelfer (IP, Munich), Counsel: Christian Judis (Compliance, Munich), Jens Knipping (Tax), Martin Weingärtner (Transactions), Managing Associates: Dr. Maximilian Backhaus (Transactions), Tim Bresemann (Real Estate), Dr. Bernhard Gröhe (Regulatory), Rolf Tichy (IP, Munich), Associate: Dr. Julia Wildgans (IP, Munich)


11. August 2025
ARQIS advises KOMI Group, initiated by Liberta Partners, on its launch through a carve-out from Konica Minolta

ARQIS provided comprehensive legal advice to the newly founded KOMI Group on the acquisition of the IT infrastructure business spun off from Konica Minolta. The spin-off took place as part of a complex carve-out. In the course of this, KOMI Group was repositioned as an independent IT service provider with a clear focus on medium-sized businesses. Konica Minolta will focus on the remaining areas of professional printing and digital business models in the future.

The new provider, KOMI Group, offers managed services, IT security solutions, infrastructure consulting and modern applications for the digital workplace for medium-sized companies. KOMI is also taking over the existing customer and project structures of Konica Minolta's former IT infrastructure business.

An ARQIS team headed by Partner Dr. Mauritz von Einem and Counsel Dennis Reisich provided comprehensive legal support to KOMI Group throughout the carve-out, acquisition and restructuring of the business. In addition to corporate law aspects, including a new corporate structure, ARQIS, headed by Lisa-Marie Niklas, advised on the carve-out from an employment law perspective. ARQIS has been working regularly for Liberta Partners for several years on transactions, successful platform investments such as the current carve-out and fund structuring.

The Munich-based investment company Liberta Partners supported the transaction as a capital provider and active sparring partner. As an entrepreneurial investment company, Liberta invests in medium-sized companies with development potential and aims to support them financially as well as develop them structurally and operationally.

 

Advisor to KOMI Group/Liberta Partners
ARQIS (Munich): Dr. Mauritz von Einem (Partner, Lead, Transactions), Lisa-Marie Niklas (Partner, Co-Lead, HR Carve-Out, Düsseldorf, HR Law), Dennis Reisich (Counsel, Co-Lead, Transactions/Tax), Partners: Johannes Landry (Düsseldorf, Financing), Dr. Ulrich Lienhard (Düsseldorf, Real Estate), Tobias Neufeld (Düsseldorf, Data Law), Marcus Nothhelfer (IP), Counsel: Nora Stratmann (Commercial), Managing Associates: Tim Bresemann, Diana Puchowezki (both Düsseldorf, Real Estate), Rolf Tichy (IP), Associates: Dr. Lina Alami, Luzia Schulze Froning (Düsseldorf, both HR Law), Rebecca Gester (Commercial), Paulina Hüttner, Dr. Julia Wildgans (both IP), Johanna Klingen (Düsseldorf, Data Law), Giulia Kögel (Transactions), Legal Specialist: Konstantinos Strempas (Transactions)


4. August 2025
ARQIS advises Katjes International on the acquisition of a majority stake in the Bogner Group

ARQIS has provided comprehensive legal advice to Katjes International on the acquisition of a sixty percent majority stake in Willy Bogner GmbH. Katjes International is acquiring the Bogner Group through its wholly owned subsidiary Katjes Quiet Luxury. 40 percent of the shares will remain with the Bogner family. The transaction, which is expected to be closed in September 2025, is still subject to approval by the German antitrust authorities. Katjes International is considering a possible increase in its existing shareholding to finance the purchase price.

Katjes International GmbH & Co. KG, with its sister companies Katjes Fassin GmbH & Co. KG and Katjesgreenfood GmbH & Co. KG, is part of the Katjes Group. Originally from the confectionery industry, Katjes International is acquiring established brands across the consumer goods sector in Europe as part of its growth strategy.

The internationally operating Bogner Group, particularly known for its ski and outdoor collections under the “Bogner” and “Bogner Fire + Ice” brands, is the largest family-run luxury clothing brand in Germany. The group focuses on premium sports and leisurewear. With over 670 employees in around 50 countries worldwide, Bogner achieved net sales of almost EUR 200 million in the 2024/25 financial year and is profitable.

ARQIS, headed by Dr. Jörn-Christian Schulze, regularly advises Katjes International on transactions.

 

ARQIS (Düsseldorf): Core Deal Team Dr. Jörn-Christian Schulze (Lead, Partner), Jasmin Grünen, Severin Steffens (Managing Associates, all Transactions), Partner: Thomas Chwalek, Johannes Landry (both Transactions), Dr. Friedrich Gebert (Regulatory), Dr. Ulrich Lienhard (Real Estate), Tobias Neufeld (HR.Law), Marcus Nothhelfer (Munich, IP), Dr. Mirjam Boche, Dr. Nicolas Rücker (both Risk), Counsel: Christian Judis (Munich, Compliance), Jens Knipping, Dennis Reisich (Munich, both Tax), Nora Stratmann (Munich, Commercial), Martin Weingärtner (HR.Law), Managing Associates: Dr. Maximilian Backhaus (Transactions), Tim Bresemann (Real Estate), Rolf Tichy (Munich, IP), Luise Schüling (Regulatory), Associates: Dr. Lina Alami (Munich), Dr. Tim Weill (both HR.Law), Dr. Maximilian Camphausen (Risk), Rebecca Gester, Paulina Hüttner (both Munich, IP), Dr. Bernhard Gröhe (Regulatory), Tim Meyer-Meisel, Steffen Schubert (both Transactions), Lia Papismedova (Real Estate), Senior Legal Specialist: Qing Xia (Transactions)

MARCK (Düsseldorf): Dr. Georg Schmittmann (Antitrust)


31. July 2025
ARQIS advises VR Equitypartner on the sale of Zimmer & Hälbig to VINCI Energies

ARQIS has advised VR Equitypartner (VREP) on the sale of its stake in Bielefeld-based refrigeration, air conditioning and ventilation specialist Zimmer & Hälbig to VINCI Energies.

Zimmer & Hälbig will be integrated into the VINCI Energies Building Solutions network, which comprises 150 business units in Germany, thereby expanding the range of multi-technical solutions for buildings.

The transaction is still subject to approval by the German competition authorities.

Zimmer & Hälbig was founded in 1974 and employed 310 people in Germany in 2024. VREP acquired a significant minority stake in Zimmer & Hälbig in 2022 as part of a management buyout and has since supported the management in implementing its growth strategy.

VR Equitypartner, a subsidiary of DZ BANK, is one of the leading equity financiers in Germany, Austria, and Switzerland. VREP's portfolio currently comprises around 40 investments with a total investment volume of EUR 400 million.

ARQIS, headed by Dr. Lars Laeger, regularly advises VREP on M&A transactions and also assisted VREP with its entry into Zimmer & Hälbig in 2022.

 

Advisors to VR Equitypartner
ARQIS (Dusseldorf): Partners: Dr. Lars Laeger (Lead), Thomas Chwalek (both Corporate/M&A), Lisa-Marie Niklas (HR Law), Johannes Landry (Financing), Counsel: Benjamin Bandur (Corporate/M&A, Munich), Jens Knipping, Dennis Reisich (Munich, both Tax), Managing Associates: Tim Bresemann (Real Estate), Rolf Tichy (IP, Munich), Conrad Wiza (Corporate/M&A), Associates: Dr. Lina Alami (HR Law), Rebecca Gester (Commercial), Senior Legal Specialist: Qing Xia (Corporate/M&A), Legal Specialist: Konstantinos Strempas (Corporate/M&A), Trademark Professional: Carolin von Fritsch


28. July 2025
ARQIS advises CURA Unternehmensgruppe on the sale of two hospital sites to MEDIAN Group

ARQIS provided comprehensive legal advice to CURA Unternehmensgruppe on the sale of its two clinic locations in Bad Saulgau, Baden-Württemberg. Following completion of the transaction, MEDIAN Group will take over Klinik am schönen Moos and Akutklinik Bad Saulgau from CURA, both specialized in acute psychosomatic and rehabilitation medicine. With around 150 employees, the facilities treat approximately 2,200 patients annually. The completion of the transaction is still subject to merger control approval.

CURA Unternehmensgruppe is a private provider of healthcare services and has been operating retirement and nursing homes as well as rehabilitation clinics since 1995. The group employs over 5,300 people at 46 locations across Germany.

MEDIAN Group is a leading European provider of services for mental health, specialized care and rehabilitation. With over 31,000 employees in 410 facilities in Germany, the UK and Spain, MEDIAN cares for more than 309,000 patients and residents annually.

An ARQIS team headed by Dr. Jörn-Christian Schulze advised CURA Unternehmensgruppe on all legal aspects of the transaction. The sale of the hospital sites was the result of a bidding process. Dr. Ulrich Lienhard, partner in the Real Estate practice at ARQIS, advised with a team on real estate law related aspects. ARQIS has provided legal support to CURA on numerous occasions. WMCF acted as M&A advisor to CURA.

 

Advisor to CURA Unternehmensgruppe
ARQIS (Dusseldorf): Core Deal Team: Dr. Jörn-Christian Schulze (Düsseldorf): Core Deal Team: Dr. Jörn-Christian Schulze (Partner, Lead), Severin Steffens (Managing Associate, both Transactions), Dr. Ulrich Lienhard (Partner, Real Estate), Partner: Thomas Chwalek (Transactions), Counsel: Jens Knipping, Dennis Reisich (Munich, both Tax), Martin Weingärtner (HR.Law), Managing Associates: Laura Ally Rizzi, Dr. Maximilian Backhaus (both Transactions), Tim Bresemann (Real Estate), Marina Bumeder (HR.Law, Munich), Luise Schüling (Regulatory), Rolf Tichy (IP, Munich), Associates: Dr. Bernhard Gröhe (Regulatory), Lia Papismedova (Real Estate), Senior Legal Specialist: Qing Xia (Transactions)


18. July 2025
ARQIS advises Brüggemann Holding GmbH on the sale of its remaining stake in the Saint-Gobain-Brüggemann-Holzbau-Group

ARQIS has advised Brüggemann Holding GmbH and its managing director, Tobias Brüggemann, on the sale of his remaining shares in the Saint-Gobain-Brüggemann-Holzbau-Group to the French building materials manufacturer Saint-Gobain.

The sale was preceded by the sale of the Saint-Gobain-Brüggemann-Holzbau-Group by Saint-Gobain to Köster Holding SE, a leading general contractor in building construction and civil engineering in Germany.

Saint-Gobain-Brüggemann-Holzbau-Group, based in Neuenkirchen, specializes in the manufacture and assembly of prefabricated timber construction solutions and employs more than 190 people.

Saint-Gobain is a global supplier of materials for the construction sector. Founded in 1665, the listed company employs around 160,000 people in 75 countries and generated sales of EUR 46.6 billion in 2024. In Germany, the company is best known for its building materials brands ISOVER, RIGIPS, WEBER and ECOPHON, as well as for its glass production.

ARQIS had already advised Brüggemann Holding GmbH and its managing director on the sale of the majority stake in the company to Saint-Gobain.

 

Advisors to Brüggemann Holding GmbH/Tobias Brüggemann
ARQIS (Dusseldorf/Munich): Andreas Dietl (Munich) Dr. Christof Alexander Schneider (Düsseldorf, both Lead, both Corporate/M&A)

Onus Consulting (Solingen): Dr. Norbert Zimmermann (Consulting)